APA (7th ed.) Citation

I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatulin, A. S. Dzharullaeva, N. M. Tukhvatulina, D. V. Shcheblyakov, . . . A. L. Gintsburg. (2017). Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

I. V. Dolzhikova, et al. Safety and Immunogenicity of GamEvac-Combi, a Heterologous VSV- and Ad5-vectored Ebola Vaccine: An Open Phase I/II Trial in Healthy Adults in Russia. Taylor & Francis Group, 2017.

MLA (9th ed.) Citation

I. V. Dolzhikova, et al. Safety and Immunogenicity of GamEvac-Combi, a Heterologous VSV- and Ad5-vectored Ebola Vaccine: An Open Phase I/II Trial in Healthy Adults in Russia. Taylor & Francis Group, 2017.